Arkolith/Insider Trading/CARA/Form 4

Reilly Thomas Charles

Chief Financial OfficerCara Therapeutics, Inc. (CARA) · full profile →Form 4 · filed Mar 4, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2022Sell(S)2K$11.38$23K38K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-016438) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML